duke street bio limited
duke street bio limited Company Information
Company Number
12714117
Next Accounts
Jan 2026
Shareholders
peter trill
harvey mcgrath
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
2 duke street, london, W1U 3EH
Website
-duke street bio limited Estimated Valuation
Pomanda estimates the enterprise value of DUKE STREET BIO LIMITED at £1.8m based on a Turnover of £1.3m and 1.38x industry multiple (adjusted for size and gross margin).
duke street bio limited Estimated Valuation
Pomanda estimates the enterprise value of DUKE STREET BIO LIMITED at £0 based on an EBITDA of £-9.5m and a 5.44x industry multiple (adjusted for size and gross margin).
duke street bio limited Estimated Valuation
Pomanda estimates the enterprise value of DUKE STREET BIO LIMITED at £24m based on Net Assets of £13.4m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Duke Street Bio Limited Overview
Duke Street Bio Limited is a live company located in london, W1U 3EH with a Companies House number of 12714117. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in July 2020, it's largest shareholder is peter trill with a 16.5% stake. Duke Street Bio Limited is a young, small sized company, Pomanda has estimated its turnover at £1.3m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Duke Street Bio Limited Health Check
Pomanda's financial health check has awarded Duke Street Bio Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
3 Weak
Size
annual sales of £1.3m, make it smaller than the average company (£3.7m)
- Duke Street Bio Limited
£3.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 34%, show it is growing at a faster rate (13.5%)
- Duke Street Bio Limited
13.5% - Industry AVG
Production
with a gross margin of 57%, this company has a comparable cost of product (57%)
- Duke Street Bio Limited
57% - Industry AVG
Profitability
an operating margin of -746.2% make it less profitable than the average company (-10.8%)
- Duke Street Bio Limited
-10.8% - Industry AVG
Employees
with 8 employees, this is below the industry average (47)
8 - Duke Street Bio Limited
47 - Industry AVG
Pay Structure
on an average salary of £82.6k, the company has an equivalent pay structure (£82.6k)
- Duke Street Bio Limited
£82.6k - Industry AVG
Efficiency
resulting in sales per employee of £158.9k, this is more efficient (£129.5k)
- Duke Street Bio Limited
£129.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Duke Street Bio Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 433 days, this is slower than average (57 days)
- Duke Street Bio Limited
57 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Duke Street Bio Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 84 weeks, this is more cash available to meet short term requirements (32 weeks)
84 weeks - Duke Street Bio Limited
32 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 7.2%, this is a lower level of debt than the average (50.8%)
7.2% - Duke Street Bio Limited
50.8% - Industry AVG
DUKE STREET BIO LIMITED financials
Duke Street Bio Limited's latest turnover from April 2024 is estimated at £1.3 million and the company has net assets of £13.4 million. According to their latest financial statements, Duke Street Bio Limited has 8 employees and maintains cash reserves of £1.7 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | 8 | 5 | 5 | 5 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | |
|---|---|---|---|---|
| Tangible Assets | ||||
| Intangible Assets | ||||
| Investments & Other | 2,630 | 2,630 | ||
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | 2,630 | 2,630 | ||
| Stock & work in progress | ||||
| Trade Debtors | ||||
| Group Debtors | ||||
| Misc Debtors | 2,897,951 | 9,968,252 | 1,006,720 | 223,874 |
| Cash | 1,698,127 | 3,662,418 | 3,721,977 | 753,967 |
| misc current assets | 9,859,430 | |||
| total current assets | 14,455,508 | 13,630,670 | 4,728,697 | 977,841 |
| total assets | 14,458,138 | 13,633,300 | 4,728,697 | 977,841 |
| Bank overdraft | ||||
| Bank loan | ||||
| Trade Creditors | 648,754 | 408,463 | 283,000 | 156,082 |
| Group/Directors Accounts | 2,630 | 2,630 | ||
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | 392,281 | 504,693 | 183,790 | 64,319 |
| total current liabilities | 1,043,665 | 915,786 | 466,790 | 220,401 |
| loans | ||||
| hp & lease commitments | ||||
| Accruals and Deferred Income | ||||
| other liabilities | ||||
| provisions | ||||
| total long term liabilities | ||||
| total liabilities | 1,043,665 | 915,786 | 466,790 | 220,401 |
| net assets | 13,414,473 | 12,717,514 | 4,261,907 | 757,440 |
| total shareholders funds | 13,414,473 | 12,717,514 | 4,261,907 | 757,440 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | ||||
| Amortisation | ||||
| Tax | ||||
| Stock | ||||
| Debtors | -7,070,301 | 8,961,532 | 782,846 | 223,874 |
| Creditors | 240,291 | 125,463 | 126,918 | 156,082 |
| Accruals and Deferred Income | -112,412 | 320,903 | 119,471 | 64,319 |
| Deferred Taxes & Provisions | ||||
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | 2,630 | |||
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | ||||
| Group/Directors Accounts | 2,630 | |||
| Other Short Term Loans | ||||
| Long term loans | ||||
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | ||||
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | -1,964,291 | -59,559 | 2,968,010 | 753,967 |
| overdraft | ||||
| change in cash | -1,964,291 | -59,559 | 2,968,010 | 753,967 |
duke street bio limited Credit Report and Business Information
Duke Street Bio Limited Competitor Analysis
Perform a competitor analysis for duke street bio limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in W1U area or any other competitors across 12 key performance metrics.
duke street bio limited Ownership
DUKE STREET BIO LIMITED group structure
Duke Street Bio Limited has no subsidiary companies.
Ultimate parent company
DUKE STREET BIO LIMITED
12714117
duke street bio limited directors
Duke Street Bio Limited currently has 7 directors. The longest serving directors include Mr Phillip Cowley (Jul 2020) and Mr Alan Wise (Jul 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Phillip Cowley | United Kingdom | 56 years | Jul 2020 | - | Director |
| Mr Alan Wise | Scotland | 56 years | Jul 2020 | - | Director |
| Mr Peter Trill | United Kingdom | 50 years | Jul 2020 | - | Director |
| Mr Alan Wise | Scotland | 56 years | Jul 2020 | - | Director |
| Mr Donnie Christian | United Kingdom | 85 years | Jun 2021 | - | Director |
| Mr Donnie Christian | United Kingdom | 85 years | Jun 2021 | - | Director |
| Sir Harvey McGrath | 73 years | Jul 2021 | - | Director |
P&L
April 2024turnover
1.3m
+77%
operating profit
-9.5m
0%
gross margin
57%
+1.87%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
13.4m
+0.05%
total assets
14.5m
+0.06%
cash
1.7m
-0.54%
net assets
Total assets minus all liabilities
Similar Companies
duke street bio limited company details
company number
12714117
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
July 2020
age
5
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
April 2024
previous names
ds bio limited (November 2020)
accountant
-
auditor
CLA EVELYN PARTNERS LIMITED
address
2 duke street, london, W1U 3EH
Bank
-
Legal Advisor
-
duke street bio limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to duke street bio limited.
duke street bio limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DUKE STREET BIO LIMITED. This can take several minutes, an email will notify you when this has completed.
duke street bio limited Companies House Filings - See Documents
| date | description | view/download |
|---|
